---

---

tags : Drug    crawled time : 11:00   

save search

---

HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
Published: 2024-04-24 (Crawled : 11:00) - globenewswire.com
HOOK | $0.8396 9.75% 9.8M |

Health Technology

| 4.19% | O: 13.6% H: 0.0% C: 0.0%
hb-700 fda pharma drug treatment clearance for application

---

NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
Published: 2024-04-08 (Crawled : 11:00) - globenewswire.com
NXTC | $1.46 -4.58% 86K |

Health Technology

| -28.84% | O: 0.93% H: 1.38% C: -5.53%
drug antibody preclinical

---

Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs
Published: 2024-04-08 (Crawled : 11:00) - prnewswire.com
LH M | $207.745 -0.11% 470K |

Health Services

| -3.55% | O: -0.19% H: 0.59% C: -0.49%
drug precision expansion research labcorp

---

Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset
Published: 2024-04-01 (Crawled : 11:00) - globenewswire.com
AGNPF | $0.089 75K |

Health Technology

| 9.76% | O: 0.37% H: 4.5% C: -11.69%
drug stroke pharmaceuticals research program

---

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
Published: 2024-04-01 (Crawled : 11:00) - globenewswire.com
SLGL | $0.9252 5.4K |

Health Technology

| -5.11% | O: 2.03% H: 4.0% C: -0.49%
ARQT | $8.9 1.83% 940K |

Health Technology

| -9.48% | O: 3.16% H: 0.0% C: -2.81%
zoryve drug collaboration

---

Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024
Published: 2024-03-28 (Crawled : 11:00) - globenewswire.com
PPBT | $0.539 10.0% 260K |

Manufacturing

| -20.97% | O: 0.0% H: 8.06% C: 8.06%
nt219 drug biotech purple

---

Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia
Published: 2024-03-28 (Crawled : 11:00) - globenewswire.com
MIST | $1.67 -1.77% 34K |

Health Technology

| -5.56% | O: 4.44% H: 0.0% C: 0.0%
etripamil drug tachycardia resubmission treatment pharmaceuticals application milestone

---

iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases
Published: 2024-03-27 (Crawled : 11:00) - globenewswire.com
IBIO | $1.86 -2.11% 90K |

Health Technology

| 65.22% | O: 133.04% H: 0.0% C: 0.0%
obesity drug collaboration

---

Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis
Published: 2024-03-20 (Crawled : 11:00) - globenewswire.com
CABA | $13.095 -1.69% 320K |

Health Technology

| -26.0% | O: 0.0% H: 1.44% C: 0.67%
caba-201 fda drug granted sclerosis treatment designation

---

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing
Published: 2024-03-14 (Crawled : 11:00) - globenewswire.com
PLUR | $5.0 5.9K |

Manufacturing

| 418.3% | O: 0.55% H: 0.95% C: -3.09%
drug cell

---

PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
Published: 2024-03-13 (Crawled : 11:00) - globenewswire.com
PEPG | $11.8 0.68% 10K |

| -15.62% | O: 1.94% H: 4.94% C: -2.9%
edo51 fda rare drug disease treatment duchenne

---

Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
TVTX | $5.375 -6.36% 620K |

Health Technology

| -31.76% | O: -0.81% H: 1.51% C: -6.98%
filspari nephropathy drug approval food treatment application therapeutics

---

Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published: 2024-03-06 (Crawled : 11:00) - biospace.com/
SNYNF | News | $94.25 480 |

Health Technology

| 0.64% | O: 0.0% H: 0.8% C: 0.8%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -1.03% | O: -0.45% H: 0.0% C: 0.0%
IPHA | $2.37 290 |

Health Technology

| -7.78% | O: 0.78% H: 1.93% C: 0.97%
iph45 pharma drug antibody preclinical

---

Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins
Published: 2024-02-14 (Crawled : 11:00) - biospace.com/
STTK | $9.78 3.06% 180K |

Health Technology

| 12.17% | O: 2.48% H: 4.38% C: 3.46%
drug collaboration agreement

---

Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
Published: 2024-01-25 (Crawled : 11:00) - globenewswire.com
UTHR | $239.7 2.23% 330K |

Health Technology

| 7.16% | O: 0.54% H: 1.08% C: -0.31%
LQDA S | $12.485 -3.59% 680K |

Health Technology

| 7.38% | O: -7.63% H: 12.84% C: 7.45%
drug corporation update application

---

GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia
Published: 2024-01-11 (Crawled : 11:00) - prnewswire.com
SLS | $1.515 -7.06% 1.3M |

Health Technology

| 196.42% | O: 1.84% H: 1.25% C: -4.34%
gfh009 fda drug t-cell granted lymphomas leukemia therapeutics

---

Aurinia Submits IND Application to US Food & Drug Administration for AUR 200
Published: 2023-12-20 (Crawled : 11:00) - ir.auriniapharma.com
AUPH | $5.02 -1.38% 580K |

Health Technology

| -46.36% | O: -1.05% H: 0.96% C: -5.11%
drug food application

---

DeFloria LLC Commences Phase 1 Clinical Program for Innovative Full Spectrum Hemp Botanical Drug
Published: 2023-12-13 (Crawled : 11:00) - prnewswire.com
CWBHF 4 | $0.2196 180K |

Process Industries

| 4.76% | O: -4.76% H: 15.35% C: 4.05%
drug program

---

Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in Japan
Published: 2023-11-13 (Crawled : 11:00) - ir.auriniapharma.com
AUPH | $5.02 -1.38% 580K |

Health Technology

| -34.24% | O: 0.13% H: 1.29% C: 0.9%
lupkynis drug japan pharmaceuticals collaboration application

---

RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device
Published: 2023-11-08 (Crawled : 11:00) - globenewswire.com
RTGN | $3.09 203.88% 400 |

n/a

| Email alert Add to watchlist
fda drug device

---

Gainers vs Losers

58%

42%

Top 10 Gainers

CSSE 4 | $0.3831 151.54% 190M |

Consumer Services

CZOO | $11.04 121.24% 11M |

LICN | $0.9107 62.63% 14M |

BOF | $1.87 59.83% 100M |

AMST | $3.18 59.0% 67M |

Technology Services

SKIL 4 | $8.72 52.72% 410K |

Information

MTC | $3.31 47.77% 7.7M |

Technology Services

MULN | News | $3.915 43.41% 12M |

Information

WIMI | $1.04 43.37% 17M |

Technology Services

RILY | $29.755 36.99% 12M |

Finance

---

Your saved searches

---